Cargando…
Paving the way to precision medicine for diabetic kidney disease: the PRIORITY trial
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812219/ https://www.ncbi.nlm.nih.gov/pubmed/33490210 http://dx.doi.org/10.21037/atm-2020-117 |
| _version_ | 1783637622876274688 |
|---|---|
| author | Schechter, Meir Leibowitz, Gil Mosenzon, Ofri |
| author_facet | Schechter, Meir Leibowitz, Gil Mosenzon, Ofri |
| author_sort | Schechter, Meir |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7812219 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78122192021-01-22 Paving the way to precision medicine for diabetic kidney disease: the PRIORITY trial Schechter, Meir Leibowitz, Gil Mosenzon, Ofri Ann Transl Med Editorial Commentary AME Publishing Company 2020-12 /pmc/articles/PMC7812219/ /pubmed/33490210 http://dx.doi.org/10.21037/atm-2020-117 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Schechter, Meir Leibowitz, Gil Mosenzon, Ofri Paving the way to precision medicine for diabetic kidney disease: the PRIORITY trial |
| title | Paving the way to precision medicine for diabetic kidney disease: the PRIORITY trial |
| title_full | Paving the way to precision medicine for diabetic kidney disease: the PRIORITY trial |
| title_fullStr | Paving the way to precision medicine for diabetic kidney disease: the PRIORITY trial |
| title_full_unstemmed | Paving the way to precision medicine for diabetic kidney disease: the PRIORITY trial |
| title_short | Paving the way to precision medicine for diabetic kidney disease: the PRIORITY trial |
| title_sort | paving the way to precision medicine for diabetic kidney disease: the priority trial |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812219/ https://www.ncbi.nlm.nih.gov/pubmed/33490210 http://dx.doi.org/10.21037/atm-2020-117 |
| work_keys_str_mv | AT schechtermeir pavingthewaytoprecisionmedicinefordiabetickidneydiseasetheprioritytrial AT leibowitzgil pavingthewaytoprecisionmedicinefordiabetickidneydiseasetheprioritytrial AT mosenzonofri pavingthewaytoprecisionmedicinefordiabetickidneydiseasetheprioritytrial |